DiaMedica Therapeutics Inc. financial data

Symbol
DMAC on Nasdaq
Location
Minneapolis, MN
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 871% % -46%
Return On Equity -83% % -91%
Return On Assets -74% % -80%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 52,077,439 shares 22%
Common Stock, Shares, Outstanding 52,077,439 shares 22%
Entity Public Float $71,000,000 USD
Common Stock, Value, Issued $0 USD
Weighted Average Number of Shares Outstanding, Basic 49,630,119 shares 16%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $24,385,000 USD 50%
General and Administrative Expense $9,218,000 USD 17%
Operating Income (Loss) $33,603,000 USD -39%
Nonoperating Income (Expense) $419,000 USD -32%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $31,899,000 USD -47%
Income Tax Expense (Benefit) $27,000 USD -37%
Net Income (Loss) Attributable to Parent $31,926,000 USD -47%
Earnings Per Share, Basic 0 USD/shares -31%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $3,326,000 USD -20%
Marketable Securities, Current $51,992,000 USD 13%
Cash, Cash Equivalents, and Short-term Investments $55,300,000 USD 10%
Accounts Receivable, after Allowance for Credit Loss, Current $260,000 USD -10%
Assets, Current $56,223,000 USD 11%
Property, Plant and Equipment, Net $150,000 USD -0.66%
Operating Lease, Right-of-Use Asset $218,000 USD -27%
Assets $57,047,000 USD 8.6%
Accounts Payable, Current $1,920,000 USD 64%
Employee-related Liabilities, Current $920,000 USD 26%
Accrued Liabilities, Current $3,239,000 USD 7.1%
Liabilities, Current $5,268,000 USD 23%
Operating Lease, Liability, Noncurrent $150,000 USD -40%
Accumulated Other Comprehensive Income (Loss), Net of Tax $50,000 USD -38%
Retained Earnings (Accumulated Deficit) $164,028,000 USD -24%
Stockholders' Equity Attributable to Parent $51,622,000 USD 7.6%
Liabilities and Equity $57,047,000 USD 8.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $7,149,000 USD -7.5%
Net Cash Provided by (Used in) Financing Activities $91,000 USD
Net Cash Provided by (Used in) Investing Activities $6,622,000 USD 57%
Common Stock, Shares, Issued 52,077,439 shares 22%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $436,000 USD 82%
Deferred Tax Assets, Valuation Allowance $34,183,000 USD 22%
Operating Lease, Liability $249,000 USD -26%
Depreciation $11,000 USD 38%
Payments to Acquire Property, Plant, and Equipment $12,000 USD 33%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $31,957,000 USD -49%
Lessee, Operating Lease, Liability, to be Paid $274,000 USD -29%
Property, Plant and Equipment, Gross $289,000 USD 14%
Operating Lease, Liability, Current $99,000 USD 12%
Lessee, Operating Lease, Liability, to be Paid, Year Two $119,000 USD 2.6%
Lessee, Operating Lease, Liability, to be Paid, Year One $116,000 USD 2.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $25,000 USD -49%
Lessee, Operating Lease, Liability, to be Paid, Year Three $10,000 USD -92%
Deferred Tax Assets, Operating Loss Carryforwards $32,240,000 USD 24%
Lessee, Operating Lease, Liability, to be Paid, Year Four $10,000 USD -92%
Additional Paid in Capital $215,600,000 USD 20%
Deferred Tax Assets, Net of Valuation Allowance $34,183,000 USD 22%
Share-based Payment Arrangement, Expense $3,243,000 USD 66%